<?xml version="1.0" encoding="UTF-8"?>
<CustomFieldTranslation xmlns="http://soap.sforce.com/2006/04/metadata">
    <label><!-- Primary Tested Drug --></label>
    <name>Primary_Tested_Drug__c</name>
    <picklistValues>
        <masterLabel>ALN-HSD</masterLabel>
        <translation><!-- ALN-HSD --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>ALN-REGN4</masterLabel>
        <translation><!-- ALN-REGN4 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>ARB-1598 (intratumoral)
ARB-1598 (SC)</masterLabel>
        <translation>
            <!-- ARB-1598 (intratumoral)
ARB-1598 (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>ASP-8374
cemiplimab</masterLabel>
        <translation>
            <!-- ASP-8374
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>BNT-111
cemiplimab</masterLabel>
        <translation>
            <!-- BNT-111
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>COVID-19 omicron variant, B.1.1.529, Regeneron</masterLabel>
        <translation><!-- COVID-19 omicron variant, B.1.1.529, Regeneron --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>COVID-19 vaccine, Moderna
casirivimab + imdevimab (intravenous)</masterLabel>
        <translation>
            <!-- COVID-19 vaccine, Moderna
casirivimab + imdevimab (intravenous) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>COVID-19 vaccine, Vyriad</masterLabel>
        <translation><!-- COVID-19 vaccine, Vyriad --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>HPV vaccine (SC), ISA Pharmaceuticals</masterLabel>
        <translation><!-- HPV vaccine (SC), ISA Pharmaceuticals --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>HPV vaccine, ISA Pharmaceuticals</masterLabel>
        <translation><!-- HPV vaccine, ISA Pharmaceuticals --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>IL-4/13 Trap, Regeneron</masterLabel>
        <translation><!-- IL-4/13 Trap, Regeneron --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>INO-9012
cemiplimab
INO-5401</masterLabel>
        <translation>
            <!-- INO-9012
cemiplimab
INO-5401 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>NTLA-2001</masterLabel>
        <translation><!-- NTLA-2001 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>Neublastin (iv)</masterLabel>
        <translation><!-- Neublastin (iv) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>PEG-Axokine</masterLabel>
        <translation><!-- PEG-Axokine --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>Phleum pratense grass tablet, ALK-Abello
dupilumab (SC)</masterLabel>
        <translation>
            <!-- Phleum pratense grass tablet, ALK-Abello
dupilumab (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-1154</masterLabel>
        <translation><!-- REGN-1154 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-1400</masterLabel>
        <translation><!-- REGN-1400 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-14284</masterLabel>
        <translation><!-- REGN-14284 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-15160</masterLabel>
        <translation><!-- REGN-15160 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-3918 (sc)</masterLabel>
        <translation><!-- REGN-3918 (sc) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-4461 (iv)
REGN-4461 (sc)</masterLabel>
        <translation>
            <!-- REGN-4461 (iv)
REGN-4461 (sc) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5054</masterLabel>
        <translation><!-- REGN-5054 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5069</masterLabel>
        <translation><!-- REGN-5069 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5093</masterLabel>
        <translation><!-- REGN-5093 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5093-M114</masterLabel>
        <translation><!-- REGN-5093-M114 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5381</masterLabel>
        <translation><!-- REGN-5381 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5381
REGN-9035</masterLabel>
        <translation>
            <!-- REGN-5381
REGN-9035 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5458</masterLabel>
        <translation><!-- REGN-5458 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5458
REGN-5459</masterLabel>
        <translation>
            <!-- REGN-5458
REGN-5459 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5458
TSA/CD28 bispecific T-cell engagers, Regeneron</masterLabel>
        <translation>
            <!-- REGN-5458
TSA/CD28 bispecific T-cell engagers, Regeneron -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5459</masterLabel>
        <translation><!-- REGN-5459 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5668</masterLabel>
        <translation><!-- REGN-5668 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5678</masterLabel>
        <translation><!-- REGN-5678 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-5713-5714-5715</masterLabel>
        <translation><!-- REGN-5713-5714-5715 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-6490</masterLabel>
        <translation><!-- REGN-6490 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-7075</masterLabel>
        <translation><!-- REGN-7075 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-728</masterLabel>
        <translation><!-- REGN-728 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-846</masterLabel>
        <translation><!-- REGN-846 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN-9933</masterLabel>
        <translation><!-- REGN-9933 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>REGN1908-1909</masterLabel>
        <translation><!-- REGN1908-1909 --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept</masterLabel>
        <translation><!-- aflibercept --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept (IV)</masterLabel>
        <translation><!-- aflibercept (IV) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept (IV)
aflibercept (SC)</masterLabel>
        <translation>
            <!-- aflibercept (IV)
aflibercept (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept (IV)
nesvacumab</masterLabel>
        <translation>
            <!-- aflibercept (IV)
nesvacumab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept (SC)</masterLabel>
        <translation><!-- aflibercept (SC) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept ophthalmic solution</masterLabel>
        <translation><!-- aflibercept ophthalmic solution --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aflibercept ophthalmic solution
rinucumab</masterLabel>
        <translation>
            <!-- aflibercept ophthalmic solution
rinucumab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab</masterLabel>
        <translation><!-- alirocumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab
cemiplimab</masterLabel>
        <translation>
            <!-- alirocumab
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab (iv)</masterLabel>
        <translation><!-- alirocumab (iv) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab (sc solution)</masterLabel>
        <translation><!-- alirocumab (sc solution) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab (sc solution)
alirocumab (SC suspension)</masterLabel>
        <translation>
            <!-- alirocumab (sc solution)
alirocumab (SC suspension) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>alirocumab (sc solution)
alirocumab (sc lyophilized formulation)</masterLabel>
        <translation>
            <!-- alirocumab (sc solution)
alirocumab (sc lyophilized formulation) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>aspirin
rivaroxaban</masterLabel>
        <translation>
            <!-- aspirin
rivaroxaban -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>atoltivimab+ maftivimab + odesivimab-ebgn</masterLabel>
        <translation><!-- atoltivimab+ maftivimab + odesivimab-ebgn --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>bevacizumab (intravitreal)
aflibercept ophthalmic solution</masterLabel>
        <translation>
            <!-- bevacizumab (intravitreal)
aflibercept ophthalmic solution -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>canakinumab (SC)</masterLabel>
        <translation><!-- canakinumab (SC) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>capecitabine
cemiplimab</masterLabel>
        <translation>
            <!-- capecitabine
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>capecitabine
oxaliplatin (IV)
aflibercept (IV)</masterLabel>
        <translation>
            <!-- capecitabine
oxaliplatin (IV)
aflibercept (IV) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>casirivimab + imdevimab</masterLabel>
        <translation><!-- casirivimab + imdevimab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>casirivimab + imdevimab
REGN-14256
imdevimab</masterLabel>
        <translation>
            <!-- casirivimab + imdevimab
REGN-14256
imdevimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>casirivimab + imdevimab (intravenous)</masterLabel>
        <translation><!-- casirivimab + imdevimab (intravenous) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>casirivimab + imdevimab (intravenous)
casirivimab + imdevimab (subcutaneous)</masterLabel>
        <translation>
            <!-- casirivimab + imdevimab (intravenous)
casirivimab + imdevimab (subcutaneous) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>casirivimab + imdevimab (subcutaneous)</masterLabel>
        <translation><!-- casirivimab + imdevimab (subcutaneous) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemdisiran
REGN-3918 (sc)</masterLabel>
        <translation>
            <!-- cemdisiran
REGN-3918 (sc) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemdisiran
pozelimab</masterLabel>
        <translation>
            <!-- cemdisiran
pozelimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemdisiran
pozelimab (iv)</masterLabel>
        <translation>
            <!-- cemdisiran
pozelimab (iv) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemdisiran
pozelimab (iv)
REGN-3918 (sc)</masterLabel>
        <translation>
            <!-- cemdisiran
pozelimab (iv)
REGN-3918 (sc) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab</masterLabel>
        <translation><!-- cemiplimab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
REGN-4336</masterLabel>
        <translation>
            <!-- cemiplimab
REGN-4336 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
REGN-4659</masterLabel>
        <translation>
            <!-- cemiplimab
REGN-4659 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
REGN-6569</masterLabel>
        <translation>
            <!-- cemiplimab
REGN-6569 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
SAR-444245</masterLabel>
        <translation>
            <!-- cemiplimab
SAR-444245 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
TSA/CD3 bispecific T-cell engagers, Regeneron</masterLabel>
        <translation>
            <!-- cemiplimab
TSA/CD3 bispecific T-cell engagers, Regeneron -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
VSV IFNb NIS, Vyriad
ipilimumab (iv)</masterLabel>
        <translation>
            <!-- cemiplimab
VSV IFNb NIS, Vyriad
ipilimumab (iv) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>cemiplimab
fianlimab</masterLabel>
        <translation>
            <!-- cemiplimab
fianlimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>colchicine</masterLabel>
        <translation><!-- colchicine --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>crotedumab</masterLabel>
        <translation><!-- crotedumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dapiclermin (sc)</masterLabel>
        <translation><!-- dapiclermin (sc) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>docetaxel
aflibercept (IV)</masterLabel>
        <translation>
            <!-- docetaxel
aflibercept (IV) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab</masterLabel>
        <translation><!-- dupilumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab
itepekimab</masterLabel>
        <translation>
            <!-- dupilumab
itepekimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab (IV)</masterLabel>
        <translation><!-- dupilumab (IV) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab (SC)</masterLabel>
        <translation><!-- dupilumab (SC) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab (SC)
itepekimab</masterLabel>
        <translation>
            <!-- dupilumab (SC)
itepekimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>dupilumab (SC)
itepekimab (SC)</masterLabel>
        <translation>
            <!-- dupilumab (SC)
itepekimab (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>enoticumab</masterLabel>
        <translation><!-- enoticumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>evinacumab</masterLabel>
        <translation><!-- evinacumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>evinacumab (IV)</masterLabel>
        <translation><!-- evinacumab (IV) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>evinacumab (IV)
evinacumab (SC)</masterLabel>
        <translation>
            <!-- evinacumab (IV)
evinacumab (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>fasinumab</masterLabel>
        <translation><!-- fasinumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>fasinumab (iv)</masterLabel>
        <translation><!-- fasinumab (iv) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>fasinumab (sc)</masterLabel>
        <translation><!-- fasinumab (sc) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>fasinumab (sc)
fasinumab (iv)</masterLabel>
        <translation>
            <!-- fasinumab (sc)
fasinumab (iv) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>fianlimab</masterLabel>
        <translation><!-- fianlimab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>garetosmab</masterLabel>
        <translation><!-- garetosmab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>hyaluronidase
aflibercept ophthalmic solution</masterLabel>
        <translation>
            <!-- hyaluronidase
aflibercept ophthalmic solution -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>infliximab (iv)
adalimumab (SC)
etanercept (SC)
certolizumab pegol (SC)
golimumab (subcutaneous)
undisclosed - anti-TNF alpha</masterLabel>
        <translation>
            <!-- infliximab (iv)
adalimumab (SC)
etanercept (SC)
certolizumab pegol (SC)
golimumab (subcutaneous)
undisclosed - anti-TNF alpha -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>isatuximab
cemiplimab</masterLabel>
        <translation>
            <!-- isatuximab
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>itepekimab</masterLabel>
        <translation><!-- itepekimab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>itepekimab (IV)
itepekimab (SC)</masterLabel>
        <translation>
            <!-- itepekimab (IV)
itepekimab (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>itepekimab (SC)</masterLabel>
        <translation><!-- itepekimab (SC) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>meningitis A/C/Y/W vaccine, Sanofi
Tdap vaccine, unspecified
dupilumab (SC)</masterLabel>
        <translation>
            <!-- meningitis A/C/Y/W vaccine, Sanofi
Tdap vaccine, unspecified
dupilumab (SC) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>mibavademab</masterLabel>
        <translation><!-- mibavademab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>motixafortide
cemiplimab</masterLabel>
        <translation>
            <!-- motixafortide
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>nesvacumab</masterLabel>
        <translation><!-- nesvacumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>nesvacumab
nesvacumab + aflibercept, Regeneron</masterLabel>
        <translation>
            <!-- nesvacumab
nesvacumab + aflibercept, Regeneron -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>nesvacumab + aflibercept, Regeneron</masterLabel>
        <translation><!-- nesvacumab + aflibercept, Regeneron --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>nirogacestat
REGN-5458</masterLabel>
        <translation>
            <!-- nirogacestat
REGN-5458 -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>odronextamab</masterLabel>
        <translation><!-- odronextamab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>odronextamab
TSA/CD28 bispecific T-cell engagers, Regeneron</masterLabel>
        <translation>
            <!-- odronextamab
TSA/CD28 bispecific T-cell engagers, Regeneron -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>odronextamab
cemiplimab</masterLabel>
        <translation>
            <!-- odronextamab
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>pexastimogene devacirepvec (IV)
pexastimogene devacirepvec (intratumoral)
cemiplimab</masterLabel>
        <translation>
            <!-- pexastimogene devacirepvec (IV)
pexastimogene devacirepvec (intratumoral)
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>phototherapy
dupilumab</masterLabel>
        <translation>
            <!-- phototherapy
dupilumab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>plerixafor (IV)
cemiplimab</masterLabel>
        <translation>
            <!-- plerixafor (IV)
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>pozelimab</masterLabel>
        <translation><!-- pozelimab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>prednisone
everolimus
sirolimus
cemiplimab</masterLabel>
        <translation>
            <!-- prednisone
everolimus
sirolimus
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>ranibizumab</masterLabel>
        <translation><!-- ranibizumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>rilonacept</masterLabel>
        <translation><!-- rilonacept --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>rinucumab</masterLabel>
        <translation><!-- rinucumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>sarilumab</masterLabel>
        <translation><!-- sarilumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>sarilumab (iv)</masterLabel>
        <translation><!-- sarilumab (iv) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>sarilumab (sc)</masterLabel>
        <translation><!-- sarilumab (sc) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>sonidegib (oral)
cemiplimab</masterLabel>
        <translation>
            <!-- sonidegib (oral)
cemiplimab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>suptavumab</masterLabel>
        <translation><!-- suptavumab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>suptavumab (im)</masterLabel>
        <translation><!-- suptavumab (im) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>suptavumab (iv)
suptavumab (im)</masterLabel>
        <translation>
            <!-- suptavumab (iv)
suptavumab (im) -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>tocilizumab (IV)</masterLabel>
        <translation><!-- tocilizumab (IV) --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>trevogrumab
garetosmab</masterLabel>
        <translation>
            <!-- trevogrumab
garetosmab -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>ubamatamab</masterLabel>
        <translation><!-- ubamatamab --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>undisclosed - antidyslipidemic agent</masterLabel>
        <translation><!-- undisclosed - antidyslipidemic agent --></translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>undisclosed - immunosuppressive drug
methotrexate
undisclosed – atopic dermatitis drug
dupilumab
cyclosporine, unspecified
corticosteroids
undisclosed-immunomodulator</masterLabel>
        <translation>
            <!-- undisclosed - immunosuppressive drug
methotrexate
undisclosed – atopic dermatitis drug
dupilumab
cyclosporine, unspecified
corticosteroids
undisclosed-immunomodulator -->
        </translation>
    </picklistValues>
    <picklistValues>
        <masterLabel>vusolimogene oderparepvec</masterLabel>
        <translation><!-- vusolimogene oderparepvec --></translation>
    </picklistValues>
</CustomFieldTranslation>
